Biblio

Add Citation
Export 135 results:
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Langston, J W  [Clear All Filters]
2007
Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson E-, Schüle B, et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology. 2007;68(12):916-22.
0
Kamel F, Tanner CM, Umbach D, Hoppin J, Alavanja MR, Blair A, et al. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol. 2007;165(4):364-74.
0
Doostzadeh J, Tetrud JW, Allen-Auerbach M, Langston JW, Schüle B. Novel features in a patient homozygous for the L347P mutation in the PINK1 gene. Parkinsonism Relat Disord. 2007;13(6):359-61.
0
2006
McCormack AL, Atienza JG, Langston JW, Di Monte DA. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration. Neuroscience. 2006;141(2):929-37.
0
2005
Goldman SM, Tanner CM, Olanow CW, Watts RL, Field RD, Langston JW. Occupation and parkinsonism in three movement disorders clinics. Neurology. 2005;65(9):1430-5.
0
Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 2005;64(2):208-15.
0
Chen L, Togasaki DM, Langston JW, Di Monte DA, Quik M. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys. Neuroscience. 2005;132(2):409-20.
0
2004
Olanow CW, Kieburtz K, Stern M, Watts R, Langston JW, Guarnieri M, et al. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease. Arch Neurol. 2004;61(10):1563-8.
0
2003
Lincoln S, Wiley J, Lynch T, Langston JW, Chen R, Lang A, et al. Parkin-proven disease: common founders but divergent phenotypes. Neurology. 2003;60(10):1605-10.
0
Chen R, Gosavi NS, Langston JW, Chan P. Parkin mutations are rare in patients with young-onset parkinsonism in a US population. Parkinsonism Relat Disord. 2003;9(5):309-12.
0
2002
Woulfe JM, Duke R, Middeldorp JM, Stevens S, Vervoort M, Hashimoto M, et al. Absence of elevated anti-alpha-synuclein and anti-EBV latent membrane protein antibodies in PD. Neurology. 2002;58(9):1435-6.
0
Tanner CM, Goldman SM, Aston DA, Ottman R, Ellenberg J, Mayeux R, et al. Smoking and Parkinson's disease in twins. Neurology. 2002;58(4):581-8.
0
Quik M, Police S, Langston JW, Di Monte DA. Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey. Neuroscience. 2002;113(1):213-20.
0
2001
Farrer M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol. 2001;50(3):293-300.
0
Yee RE, Irwin I, Milonas C, Stout DB, Huang SC, Shoghi-Jadid K, et al. Novel observations with FDOPA-PET imaging after early nigrostriatal damage. Mov Disord. 2001;16(5):838-48.
0
Tanner CM, Goldman SM, Lyons KE, Aston DA, Tetrud JW, Welsh MD, et al. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology. 2001;57(8):1389-91.
0
Forno L, Langston JW. Clinical and neuropathological features: session III summary and research needs. Neurotoxicology. 2001;22(6):833-5.
0
Togasaki DM, Tan L, Protell P, Di Monte DA, Quik M, Langston JW. Levodopa induces dyskinesias in normal squirrel monkeys. Ann Neurol. 2001;50(2):254-7.
0
2000
Quik M, Polonskaya Y, Gillespie A, Jakowec M, K Lloyd G, Langston JW. Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization. J Comp Neurol. 2000;425(1):58-69.
0
Langston JW, Tan LC. Juvenile parkinsonism: a term in search of an identity. Eur J Neurol. 2000;7(5):465-6.
0
Yee RE, Huang SC, Stout DB, Irwin I, Shoghi-Jadid K, Togaski DM, et al. Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations. J Neurochem. 2000;74(3):1147-57.
0
Snow BJ, Vingerhoets FJ, Langston JW, Tetrud JW, Sossi V, Calne DB. Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J Neurol Neurosurg Psychiatr. 2000;68(3):313-6.
0
McGrew DM, Irwin I, Langston JW. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice. Neurotoxicology. 2000;21(3):309-12.
0
Thiffault C, Langston JW, Di Monte DA. Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res. 2000;885(2):283-8.
0
Langston JW, Tanner CM. Selegiline and Parkinson's disease: it's déjà vu-again. Neurology. 2000;55(12):1770-1.
0